MeSH D008708 - methemoglobinemia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Alfasigma | Methylene blue | Lumeblue (previously Methylthioninium Cosmo) | 2020-08-19 | |||
| Hikma Pharmaceuticals | Methylene blue | Methylene Blue | 2024-12-17 | |||
| Meitheal Pharmaceuticals | Methylene blue | Methylene Blue | 2025-01-23 | |||
| Nexus Biopharma | Methylene blue | Methylene Blue | 2024-11-21 | |||
| Provepharm | Methylene blue | Provayblue | 2016-04-08 | |||
| Methylene blue | Methylthioninium Proveblue | 2011-05-06 |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/2
Phase 2
0%0/0
Phase 3
100%2/2
Approved: 2Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use